Nutrition Optimalization Among Pregnant Women to Improve Maternal and Neonatal Outcome in DKI Jakarta
MONAS
Maternal Optimalization on Nutrition for Better Pregnancy Outcomes (MONAS Study)
1 other identifier
interventional
245
1 country
1
Brief Summary
The goal of this MONAS Study is to learn about comprehensive monitoring and nutritional intervention among pregnant women in order to improve maternal and neonatal outcomes. The main questions it aims to answer are:
- Fetomaternal ultrasound examination each trimester
- Complete laboratory examination for nutritional panel (complete blood count with reticulocyte profile and iron profile, vitamin D level, zinc level, fatty acid profile, electrophoresis for Thalassemia) as an addition to standard maternal routine laboratory examination
- Supplements: multivitamin, minerals, vitamin D, fatty acid
- Intervention regarding any abnormal results of nutritional panel
- All standard maternal health services according to Indonesian Ministry of Health protocol Participants in the control group will receive: \- All standard maternal health services according to Indonesian Ministry of Health protocol
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2023
CompletedFirst Submitted
Initial submission to the registry
January 30, 2024
CompletedFirst Posted
Study publicly available on registry
February 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedFebruary 20, 2024
February 1, 2024
1.2 years
January 30, 2024
February 16, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Composite of poor maternal outcomes
Number of participants with a combination of maternal death, preterm labour, preeclampsia, intrauterine infection, and bleeding during pregnancy and or after delivery
At anytime between 20 weeks of gestational age until 28 days after delivery
Composite of poor neonatal outcomes
A number of baby born from participants with a combination of neonatal death, low birth weight, intrauterine growth restriction, neonatal asphyxia, and need of admission to intensive care untill 28 daya of age
After delivery of participants (any gestational age) until 28 days of chronological age
Study Arms (2)
Intervention group
EXPERIMENTALParticipants in the intervention group will receive: * Fetomaternal ultrasound examination each trimester by fetomaternal consultants * Complete laboratory examination for nutritional panel (complete blood count with reticulocyte profile and iron profile, vitamin D level, zinc level, fatty acid profile, electrophoresis for Thalassemia) as an addition to standard maternal routine laboratory examination * Supplements: multivitamin, minerals, vitamin D, fatty acid * Intervention regarding any abnormal results of nutritional panel * All standard maternal health services according to Indonesian Ministry of Health protocol
Control group
NO INTERVENTIONParticipants in the control group will receive: \- All standard maternal health services according to Indonesian Ministry of Health protocol
Interventions
As stated in group description
As stated in group description
Eligibility Criteria
You may qualify if:
- Pregnancy in 1st trimester
- Gestational age less than 10 weeks
- Living in Jakarta greater area
- Agree to participate
You may not qualify if:
- Assisted reproductive technology (IVF)
- History of polycystic ovary syndrome
- History of chronic hypertension
- History of diabetes mellitus
- History of preeclampsia in the previous pregnancy
- Had chronic disease: heart disease, autoimmune disease, malignancy, chronic lung disease
- Planning to have delivery outside Jakarta greater area
- Poor obstetric history (miscarriage/ abortion more than 3 times)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dr Cipto Mangunkusumo General Hospitallead
- Dinas Kesehatan DKI Jakartacollaborator
- Fakultas Kedokteran Universitas Indonesiacollaborator
Study Sites (1)
Jakarta Primary Care Health Facility (Puskesmas) under Jakarta Health Office
Jakarta, Indonesia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rinawati Rohsiswatmo, Prof., M.D., Ph.D.
Dr Cipto Mangunkusumo Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Member of Department of Child Health
Study Record Dates
First Submitted
January 30, 2024
First Posted
February 20, 2024
Study Start
April 1, 2023
Primary Completion
June 1, 2024
Study Completion
August 1, 2024
Last Updated
February 20, 2024
Record last verified: 2024-02